[1st results of clinical trials of a phospholipid complex from bovine brain in mental syndromes].
D000328:Adult; D000368:Aged; D000818:Animals; D001714:Bipolar Disorder / Q000628:therapy; D001921:Brain; D002417:Cattle; D003704:Dementia / Q000628:therapy; D003863:Depression / Q000628:therapy; D004827:Epilepsy / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000628:therapy*; D008875:Middle Aged; D009069:Movement Disorders / Q000628:therapy; D019965:Neurocognitive Disorders / Q000628:therapy; D009771:Obsessive-Compulsive Disorder / Q000628:therapy; D010743:Phospholipids / Q000627:therapeutic use*; D011612:Psychosurgery / Q000009:adverse effects; D012559:Schizophrenia / Q000628:therapy; D014020:Tissue Extracts / Q000627:therapeutic use*
D010743:Phospholipids; D014020:Tissue Extracts
Premiers résultats d'essais cliniques d'un complexe phospholipidique de cerveaux de bovidés dans les syndromes mentaux.